HealthStream director Linda Rebrovick sells $420,000 in stock
What it means
- What to watch: The headline hangs on one number ($420,000) — one data point is a snapshot, so the trailing trend is the context it needs.
- How the stock is trading: $HSTM +1.65% in the latest session.
- Timing: Weekend news: the change beside it is Friday's, and Monday's open is the first session that gets a say. Market holidays are not detected.
Where the stock stands
$HSTM last changed hands at $35.16, +1.65% on the session, 0.2% below its 52-week high of $35.23 and 80% above its low of $19.50 — within a tenth of its 52-week high. Over the year it has ranged 81% from low to high: a wide band, so a several-percent week is just a week. These are latest-session quotes, not live prices — the live tape is on the $HSTM page.
How much coverage it is getting
In the last 30 days Wook has filed 1 story about $HSTM — 1 of them this week. At its 30-day pace you would expect about 0 a week, so this week is running well ahead of normal — something has the newsroom's attention. Across those stories the wording ran 0% bullish, 100% neutral and 0% bearish. This one reads neutral, so it sits squarely with the crowd. This is the only one from Investing.com; the rest came from other outlets. 12 of them are lined up beside this one if you want the whole thread.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
Coming up
$HSTM earnings in 9 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
For the receipts, the $HSTM page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $HSTM sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $HSTM. It carried $420,000, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.